Cancer Metabolomics

Based on gene expression and DNA grouping, cancer genomics controls how the contrast between tumour cells and regular cells is portrayed. The goal of this inquiry is to better understand the fundamental hereditary characteristics of tumour progression, the alteration of the disease's genome, and the role of treatment in the cancer microenvironment. The study of the chemical traces a metabolite leaves behind during digestion is known as metabolomics. Examining the metabolite profile for sedative improvement in the event of the presence of tumour cells will be of the utmost importance. One of the many discoveries in disease metabolomics is the noninvasive validation of metabolic biomarkers from the bodily fluid of tumour patients.

    Related Conference of Cancer Metabolomics

    April 16-17, 2025

    9th International Conference on Internal Medicine

    Berlin, Germany
    May 12-13, 2025

    19th International Conference on Obesity Medicine

    Toronto, Canada
    June 24-25, 2025

    3rd Global Summit on HIV-AIDS and STDs

    Chicago, USA
    July 21-22, 2025

    24th International Conference on Genomics and Molecular Biology

    Aix-en-Provence, France
    July 21-22, 2025

    11th World Congress on Anesthesia and Critical Care

    Aix-en-Provence, France
    August 07-08, 2025

    12th World Summit on Epilepsy and Bipolar Disorders

    Paris, France
    August 25-26, 2025

    8th International Conference on Community Nursing and Public Health

    Singapore City, Singapore
    September 22-23, 2025

    39th International Conference on Cancer Science & Therapy

    Amsterdam, Netherlands
    October 16-17, 2025

    19th International Conference on Pathology and Laboratory Medicine

    Aix-en-Provence, France
    November 03-04, 2025

    5th World Medicine Congress

    Rome, Italy

    Cancer Metabolomics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in